November 9, 2017 — Abbott received European CE mark for Xience Sierra, the newest generation of the company's Xience ...
A discussion with William W. O’Neill, M.D., medical director, Center for Structural Heart Disease, Henry Ford Hospital ...
November 8, 2017 — Physicians at UnityPoint Health Methodist, Peoria, Ill., are now offering fast, safe and accurate ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
John Rhodes, M.D., co-director of the adult congenital heart program, Medical University of South Carolina, is the ...
Juan Granada, M.D., Cardiovascular Research Foundation president and chief executive officer, shares his insights on ...
November 8, 2017 – New results from the HARMONEE Japan/U.S. Registration Trial, reported by in a first report ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference, Oct. 29-Nov. 2 in Denver.
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut Transcatheter Aortic Valve Replacement (TAVR) Platform in intermediate-risk, severe, symptomatic, aortic stenosis patients. Outcomes from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI) Trial and the Evolut R FORWARD “real-world” study were presented at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) Annual Meeting, Oct. 29-Nov. 2 in Denver, reinforcing the valve’s strong performance in healthier, more active patients.
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the ...
A discussion with Ajay Kirtane, M.D., SM, director of the cardiac catheterization laboratories at New York-Presbyterian ...
November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and can ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state of ...
November 7, 2017 — Medtronic plc recently presented positive data for its self-expanding Intrepid transcatheter mitral ...
http://www.tctconference.comA new study has found that a pioneering device to repair heart valves is safe and effective, and can reduce the invasiveness and side effects of conventional mitral valve surgery. The Harpoon Mitral Valve Repair System (H-MVRS), an image-guided device based on technology developed at the University of Maryland School of Medicine (UMSOM), is deployed through a small opening between the ribs, and repairs the heart while it continues to beat. The research was presented at the Transcatheter Cardiovascular Therapeutics (TCT 2017) symposium, Oct. 29-Nov. 2 in Denver, and simultaneously published in the Journal of the American College of Cardiology (JACC).